SQZ Biotechnologies Company (SQZB)
USD 0.03
(0.0%)
USD 0.03
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2022 | -36.23 Million USD | 50.91% |
| 2021 | -73.82 Million USD | 40.11% |
| 2020 | -123.26 Million USD | -4107.22% |
| 2019 | 3.07 Million USD | 105.16% |
| 2018 | -59.57 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q2 | -2.35 Million USD | 84.71% |
| 2023 Q1 | -15.37 Million USD | 57.58% |
| 2023 Q3 | 11.27 Million USD | 579.75% |
| 2022 Q1 | -55.59 Million USD | 24.69% |
| 2022 Q3 | -21.78 Million USD | 46.37% |
| 2022 Q4 | -36.23 Million USD | -66.31% |
| 2022 Q2 | -40.63 Million USD | 26.92% |
| 2022 FY | -36.23 Million USD | 50.91% |
| 2021 Q3 | -92.69 Million USD | 0.0% |
| 2021 FY | -73.82 Million USD | 40.11% |
| 2021 Q4 | -73.82 Million USD | 20.36% |
| 2020 FY | -123.26 Million USD | -4107.22% |
| 2019 FY | 3.07 Million USD | 105.16% |
| 2018 FY | -59.57 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1310.00 USD | -2766159.542% |
| Arch Therapeutics, Inc. | 5.64 Million USD | 741.566% |
| Evofem Biosciences, Inc. | 42.79 Million USD | 184.682% |
| Nascent Biotech, Inc. | -249.62 Thousand USD | -14417.266% |
| Rebus Holdings, Inc. | 305 Thousand USD | 11981.311% |
| Santhera Pharmaceuticals Holding AG | -6.3 Million USD | -474.794% |
| Qrons Inc. | 351.42 Thousand USD | 10411.672% |
| Adynxx, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | 622.36 Thousand USD | 5922.638% |
| Northwest Biotherapeutics, Inc. | 43.43 Million USD | 183.432% |
| ProtoKinetix, Incorporated | -20.4 Thousand USD | -177467.621% |
| Skye Bioscience, Inc. | -5.72 Million USD | -533.378% |
| Eiger BioPharmaceuticals, Inc. | 15.76 Million USD | 329.893% |
| Nanobac Pharmaceuticals, Incorporated | 4.11 Million USD | 979.985% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | 9117.815% |
| Intellipharmaceutics International Inc. | 2.24 Million USD | 1716.157% |
| Propanc Biopharma, Inc. | 927.18 Thousand USD | 4008.385% |
| Mesoblast Limited | 55.85 Million USD | 164.875% |
| Marizyme, Inc. | 18.56 Million USD | 295.153% |
| Genus plc | 190.6 Million USD | 119.013% |
| VioQuest Pharmaceuticals, Inc. | 2.23 Million USD | 1720.784% |
| Pharming Group N.V. | 109.8 Million USD | 133.002% |
| Therapeutic Solutions International, Inc. | 860.24 Thousand USD | 4312.54% |
| CNBX Pharmaceuticals Inc. | 1.21 Million USD | 3085.284% |
| Nymox Pharmaceutical Corporation | 680 Thousand USD | 5429.118% |
| ContraFect Corporation | -6.02 Million USD | -501.361% |
| PsyBio Therapeutics Corp. | 134.63 Thousand USD | 27014.935% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.15 Million USD | 3236.324% |
| IMV Inc. | 7.67 Million USD | 572.432% |
| AXIM Biotechnologies, Inc. | 5.5 Million USD | 758.646% |
| MultiCell Technologies, Inc. | 90.04 USD | 40246657.086% |
| ONE Bio Corp. | 9.04 Million USD | 500.861% |
| Accustem Sciences Inc. | -733.97 Thousand USD | -4837.205% |
| RVL Pharmaceuticals plc | 12.94 Million USD | 379.917% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | 1.36 Million USD | 2749.033% |
| Q BioMed Inc. | 4.06 Million USD | 992.56% |
| Emmaus Life Sciences, Inc. | 30.55 Million USD | 218.603% |
| Mosaic ImmunoEngineering Inc. | 1 Million USD | 3696.053% |
| Biomind Labs Inc. | 711.4 Thousand USD | 5193.885% |
| American Oriental Bioengineering, Inc. | 60.54 Million USD | 159.852% |
| Provectus Biopharmaceuticals, Inc. | 1.99 Million USD | 1912.451% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | 12.8 Million USD | 382.964% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | 10174.226% |
| THC Farmaceuticals, Inc. | 139.8 Thousand USD | 26020.575% |
| Acro Biomedical Co., Ltd. | 19.86 Thousand USD | 182502.98% |
| Curative Biotechnology, Inc. | 2.2 Million USD | 1745.7% |
| GB Sciences, Inc. | 1.74 Million USD | 2173.924% |
| Alpha Cognition Inc. | -183.78 Thousand USD | -19617.283% |
| HST Global, Inc. | 96.79 Thousand USD | 37538.658% |
| CSL Limited | 10.52 Billion USD | 100.344% |
| Wesana Health Holdings Inc. | 206.21 Thousand USD | 17672.751% |
| Halberd Corporation | 144.72 Thousand USD | 25139.904% |
| Enzolytics Inc. | 981.65 Thousand USD | 3791.517% |
| Agentix Corp. | 37.63 Thousand USD | 96398.265% |
| Resverlogix Corp. | 6.45 Million USD | 661.742% |
| Nuo Therapeutics, Inc. | -673.08 Thousand USD | -5283.835% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -2.02 Billion USD | 98.214% |
| Enzon Pharmaceuticals, Inc. | -47.01 Million USD | 22.918% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | 612.49% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | 1437.879% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -8.83 Million USD | -309.936% |
| AVAX Technologies, Inc. | -5.9 Million USD | -513.87% |
| Zenith Capital Corp. | 10.06 Thousand USD | 360175.517% |
| Genscript Biotech Corporation | -1.06 Billion USD | 96.586% |
| Ember Therapeutics, Inc. | 200.43 Thousand USD | 18179.947% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | 2.38 Million USD | 1618.755% |
| WPD Pharmaceuticals Inc. | 164.5 Thousand USD | 22127.974% |
| Cotinga Pharmaceuticals Inc. | -18.31 Thousand USD | -197727.274% |
| Kadimastem Ltd | -253.1 Thousand USD | -14217.548% |
| Helix BioMedix, Inc. | -2.57 Million USD | -1310.021% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | 20.27 Million USD | 278.724% |
| BioStem Technologies, Inc. | 4.47 Million USD | 910.329% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | 201.25 Thousand USD | 18106.102% |
| LadRx Corporation | -2.03 Million USD | -1679.453% |
| Cell Source, Inc. | 9.23 Million USD | 492.527% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | 5805.271% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | 5805.271% |
| NovAccess Global Inc. | 2.17 Million USD | 1763.465% |
| Affymax, Inc. | -5.59 Million USD | -547.454% |
| Itoco Inc. | 228.3 Thousand USD | 15972.627% |
| Rasna Therapeutics, Inc. | 135.98 Thousand USD | 26747.744% |
| Pathfinder Cell Therapy, Inc. | 4.95 Million USD | 831.047% |
| Mobile Lads Corp. | 484.23 Thousand USD | 7583.603% |
| CytoDyn Inc. | 20.26 Million USD | 278.847% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -647.00 USD | -5600827.357% |
| NanoSphere Health Sciences Inc. | -9268.34 USD | -390886.951% |
| Alseres Pharmaceuticals, Inc. | 7.7 Million USD | 570.257% |
| SYBLEU INC | 473.71 Thousand USD | 7749.763% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 4.45 Million USD | 913.054% |
| International Stem Cell Corporation | 2.59 Million USD | 1499.151% |
| Bioxytran, Inc. | 1.89 Million USD | 2008.354% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | 58161.622% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | 1761.608% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | 3.43 Million USD | 1155.271% |
| Adhera Therapeutics, Inc. | 8.55 Million USD | 523.688% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | 772.6 Thousand USD | 4790.354% |
| Innovation Pharmaceuticals Inc. | -1.25 Million USD | -2799.04% |
| Neutra Corp. | 52.18 Thousand USD | 69538.749% |
| Windtree Therapeutics, Inc. | -2.48 Million USD | -1355.926% |
| PureTech Health plc | -167.19 Million USD | 78.326% |
| Coeptis Therapeutics, Inc. | -244.9 Thousand USD | -14696.577% |
| IXICO plc | -4.44 Million USD | -715.329% |
| IntelGenx Technologies Corp. | 13.21 Million USD | 374.136% |
| Gelesis Holdings, Inc. | 54.85 Million USD | 166.066% |
| CSL Limited | 10.52 Billion USD | 100.344% |
| Cellectis S.A. | -43.81 Million USD | 17.3% |